These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 16902162

  • 1. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
    Imagawa S, Fujii S, Dong J, Furumoto T, Kaneko T, Zaman T, Satoh Y, Tsutsui H, Sobel BE.
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
    [Abstract] [Full Text] [Related]

  • 2. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
    Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, Sobel BE, Fujii S.
    Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
    [Abstract] [Full Text] [Related]

  • 3. Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene.
    White LA, Bruzdzinski C, Kutz SM, Gelehrter TD, Higgins PJ.
    Exp Cell Res; 2000 Oct 10; 260(1):127-35. PubMed ID: 11010817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
    Dong J, Fujii S, Li H, Nakabayashi H, Sakai M, Nishi S, Goto D, Furumoto T, Imagawa S, Zaman TA, Kitabatake A.
    Arterioscler Thromb Vasc Biol; 2005 May 10; 25(5):1078-84. PubMed ID: 15718495
    [Abstract] [Full Text] [Related]

  • 6. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z, Jhun B, Jung SY, Oh CK.
    J Allergy Clin Immunol; 2008 Apr 10; 121(4):1006-1012.e2. PubMed ID: 18234320
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Upstream stimulating factor-1 mediates the E-box-dependent transcriptional repression of the plasminogen activator inhibitor-1 gene in human mast cells.
    Ma Z, Jhun B, Oh CK.
    FEBS Lett; 2007 Sep 18; 581(23):4485-90. PubMed ID: 17765897
    [Abstract] [Full Text] [Related]

  • 9. The MAPK pathway and HIF-1 are involved in the induction of the human PAI-1 gene expression by insulin in the human hepatoma cell line HepG2.
    Dimova EY, Kietzmann T.
    Ann N Y Acad Sci; 2006 Dec 18; 1090():355-67. PubMed ID: 17384280
    [Abstract] [Full Text] [Related]

  • 10. The concerted regulatory functions of the transcription factors nuclear factor-1 and upstream stimulatory factor on a composite element in the promoter of the hepatocyte growth factor gene.
    Jiang JG, Gao B, Zarnegar R.
    Oncogene; 2000 May 25; 19(23):2786-90. PubMed ID: 10851080
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
    Tan R, Zhang X, Yang J, Li Y, Liu Y.
    J Am Soc Nephrol; 2007 Aug 25; 18(8):2340-9. PubMed ID: 17625116
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW, Chen Q, Zarnegar R.
    Oncogene; 2000 Feb 24; 19(9):1132-7. PubMed ID: 10713700
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
    Gaggioli C, Deckert M, Robert G, Abbe P, Batoz M, Ehrengruber MU, Ortonne JP, Ballotti R, Tartare-Deckert S.
    Oncogene; 2005 Feb 17; 24(8):1423-33. PubMed ID: 15608673
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M, Ikeda T, Saito T, Ogawa K, Nishino Y, Nakaya K, Funaba M.
    Cell Signal; 2006 Feb 17; 18(2):256-65. PubMed ID: 15961275
    [Abstract] [Full Text] [Related]

  • 17. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
    Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N.
    J Mol Cell Cardiol; 2009 Apr 17; 46(4):545-52. PubMed ID: 19168071
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, Mori H.
    Hepatology; 2001 Mar 17; 33(3):569-76. PubMed ID: 11230736
    [Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C, Garcia-Trevijano ER, Ludwiczek O, Talabot D, Kaser A, Mato JM, Fritsche G, Weiss G, Gabay C, Avila MA, Tilg H.
    Eur Cytokine Netw; 2004 Mar 17; 15(4):303-11. PubMed ID: 15627638
    [Abstract] [Full Text] [Related]

  • 20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 17; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.